Latest Updates on GLPG
-
Biotechnology Profit on This Biotech-Enabler That’s Suddenly a “Buy”
"Lead, follow, or get out of the way." This is one of those well-known aphorisms that's been around forever - though its originator is unknown. Truth be told, it doesn't matter who said it first. … Read more » -
Stocks This Deal Could Put You Up Much More Than 149%
It was the very first stock that I recommended on the very first day we published Private Briefing nearly eight years ago... I've re-recommended the shares to my readers several times, and when something happened that I felt everyone should … Read more » -
Stocks Here Are the Best Stocks to Buy Now
Our new list of best stocks to buy now features a few Money Morning all-stars riding new catalysts. Plus, we've got a couple newcomers riding unstoppable trends. Read more » -
biotech A New "Super Drug" Will Send This Biotech Stock Skyrocketing
One of the biggest waves in healthcare now is the care and treatment of the aging population. Among the more common maladies we face as we get older is arthritis - and specifically rheumatoid arthritis (RA). It's big deal, too. RA the third … Read more » -
Biotechnology This Baby Biotech Has Lots of Running Room, Thanks to This Upcoming "Super" Drug
Our Bill Patalon first introduced this biotech company to you on the very first day he published his Private Briefing service, and it's been a huge winner for you since. Read more » -
Stocks Our Top Stocks to Watch Now Are McDonald's, Galapagos, and Fossil
Our latest list of stocks to watch now includes the world's largest fast-food chain expanding in China, our top-performing stock pick advancing a promising new drug, and a fashion retailer facing extinction. Read more » -
Stocks Every Stock on This List Will Triple the S&P 500's Returns
Here at Money Morning, we work with a team of 11 investing and market professionals who've invested real money for themselves and others over the decades they've spent in their respective fields. In fact, as a group, these folks have close … Read more » -
stocks Biotech Stocks 2017: The Best Way to Beat the Market This Year
Biotech stocks in 2017 are beating the markets with nearly double the gains of the Dow. And the biotech sector is expected to continue beating the markets this year. But not all biotech stocks are worth the investment. Picking the right … Read more » -
Stocks Money Morning Top Outperformers
Here are Money Morning's top ten stock picks recommended by our gurus, ranked by how much they outperformed the S&P 500. Read more » -
Biotechnology Our "War on Pain" Biotech Put You Up by Double Digits in Just Two Weeks
Insys Therapeutics - our "War on Pain" biotech play - has given us a profit of more than 10.7% since we recommended the stock a little less than two weeks ago. I hope you like profits, because that's just for starters. The U.S. Food … Read more » -
Stocks Update: My Favorite "Ten Bagger" Could Zoom Another 48%
We've talked about the stellar "Baby Biotech" I'm going to update you on today. It's actually the first stock I ever recommended in Private Briefing, back in 2011. At the time, you could buy it for less than nine bucks a share - $8.60. … Read more » -
Stocks Three Stocks to Buy Now That Keep Delivering Big Gains
Some of the best stocks to buy now have already logged impressive gains. These are stocks that keep rising higher over time. While many investors would be tempted to take their initial profits and walk, Money Morning Executive Editor Bill … Read more » -
Stocks 5 of the Best Stocks to Buy Right Now
When markets fall, the best stocks to buy right now will not get hit as badly as the broader index. That's because healthy companies can see share prices rebound faster than average companies... These are the stocks to buy for long-term … Read more » -
Stocks Celebrate This High-Profit Milestone with Some More Triple-Digit Gains
This was the very first stock we recommended on the very first day Private Briefing was published - Aug. 11, 2011. On that day, you could've owned it for less than nine bucks a share - $8.60. That's a distant memory. We've … Read more »
